SavedAdd your journal

Journals / Medicine Science / 2017 / Cilt: 6 - Sayı: 2

Seroprevalence of Hepatitis A Virus in Inonu University Medical Faculty Hospital, 2015

YÜCEL DUMAN
MEHMET SAİT TEKEREKOĞLU
SELMA AY
Ayfer SERİNDAĞ
Pages
233–235
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that; the data contributes to evaluate the preventive measures, immunization program studies and determination of vaccine efficacy studies

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatitis A is the most common pathogen that causes acute viral hepatitis in humans.
📊
Key Findings & Data:The presence of anti-HAV IgG and IgM antibodies were evaluated retrospectively from 7275 serum samples which sent to our hospitals’ microbiology laboratory in 2015.
💡
Conclusion & Impact:We believe that; the data contributes to evaluate the preventive measures, immunization program studies and determination of vaccine efficacy studies
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Hepatitis A is the most common pathogen that causes acute viral hepatitis in humans. HAV infection is considered as an important public health concern. The aim of this study was to assess the seroprevalence of anti-HAV IgG and IgM antibodies in our hospital. The presence of anti-HAV IgG and IgM antibodies were evaluated retrospectively from 7275 serum samples which sent to our hospitals’ microbiology laboratory in 2015. The presence of anti-HAV IgG and IgM antibodies in serum samples were studied by using macro ELISA Abbott - Architect i2000 system test kits. The 7275 patients’ serum samples were analyzed. The 74.4% of analyzed samples were positive for anti-HAV IgG antibodies. Anti-HAV IgM antibody positivity rate was found as 1.3%. The 87.4% of antiHAV IgM positive cases were under the age of 16 and 12.6% were at adulthood stage. The incidence of acute viral hepatitis disease could be reduced by improving hygiene conditions, personal hygiene education, routine vaccination activities, correcting infrastructure and informing people about HAV. We believe that; the data contributes to evaluate the preventive measures, immunization program studies and determination of vaccine efficacy studies

🔖

Cite This Article

DUMAN, Y., TEKEREKOĞLU, M. S., AY, S., SERİNDAĞ, A. (2017). Seroprevalence of Hepatitis A Virus in Inonu University Medical Faculty Hospital, 2015. Medicine Science, Cilt: 6 - Sayı: 2, 233–235. https://ajindex.com/articles/277349

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Yoldaş Ö, Bulut A, Altındiş M. Hepatit A Enfeksiyonlarına Güncel Yaklaşım. Viral Hepatitis J. 2012;18(3):81–6
  2. Mıstık R. Viral Hepatitler. Ed. Altındiş M. Hemşireler için mikrobiyoloji. İstanbul, Nobel Medical Bookstores, 2010;268–9
  3. Hepatitis A. http://www.who.int/mediacentre/factsheets/fs328/en/ access date 19.04.2015 4. Kara Hİ. Acute viral hepatitis A. Turkish Family Med J. 2007;11(4):177–84
  4. Yapıcıoğlu H, Alhan E, Yıldızdaş D, Yaman A, Bozdeir N. Prevalence of hepatitis A in children and adolescents in Adana, Turkey. Indian Pediatr. 2002;39(10):936–41
  5. Türker T, Babayiğit MA, Tekbaş ÖF, Oğur R, Avcı Yİ, Pahsa A, Hasde M. GATA Eğitim ve Araştırma Hastanesi’ne 2002–2004 yılları arasında viral hepatit nedenli yatışların sıklığı ve dağılımı. Gülhane Med J. 2006;48(3):125–31
  6. Ceyhan MN. Ankara’da bir ilköğretim okulunda hepatit A seropozitiflik prevalansı ve etkileyen etmenler ile bir yıllık insidansı (Thesis). Ankara: Gazi University Medicine Faculty, Department of Public Health, 2007
  7. Arslan K. Çocukluk çağı hepatit A seroprevalansı (Thesis). İstanbul: T.C. Sağlık Bakanlığı, Haseki Training and Research Hospital, Department of Child Health and Diseases, 2006
  8. Turhan V. Ulusal Aşılama Programında Olmayan Aşılara EHKM Gözüyle Bakış; Hepatit A Aşısı. 4.EKMUD Kongre Kitabı. İstanbul, 9-12 Mayıs 2012;84–5
  9. Yavrucu S, Yücel O, Sahin R. 2–14 yas arası çocuklarda hepatit A prevalansı ve sosyoekonomik dağılımı. Taksim Training and Research Hosp Med J. 2001;31(3):50–3
  10. Tekay F. Hakkâri Devlet Hastanesine Başvuran 0–14 Yaş Grubu Çocuklarda Hepatit A Sıklığı. Dicle Med J. 2006;33(4):245–7
  11. Badur S. Viral Hepatit Aşılarında Neredeyiz? XXXIV. Türk Mikrobiyoloji Kongre Kitabı. Girne, 7–11 Kasım 2010;35–8
  12. Tosun S, Ayaz H, Deveci S, Aksu S. Çocuk ve Erişkinlerde Hepatit A Virüsü ile Karşılaşma Durumunun Değerlendirilmesi. X.Ulusal Viral Hepatit Kongre Kitabı. Antalya, 01–04 Nisan 2010;121
  13. Tosun S, Yıldız O, Tekinkoruk S ve ark. Kronik HBV ve HCV Olgularının HAV ile Karşılaşma Durumlarını Yeterince Değerlendiriyor muyuz? XI. Ulusal Viral Hepatit Kongre Kitabı. Antalya, 12–15 Nisan 2012;80–1
  14. Temiz H, Özbek E, Toprak SF ve ark. Güneydoğu Anadolu’da bir Eğitim ve Araştırma hastanesine başvuran hastalarda hepatit A seroprevalansı. Dicle Tıp Derg. 2015;42(4):485–9
  15. Kumbasar H, Tabak F, Özaras R ve ark. Kronik Hepatitli Hastalarda Hepatit A Virüsü Seroprevalansı. Viral Hepatitis J. 2004;9(3):152–5
  16. Çetinkol Y, Yıldırım